Quality of life assessment in international breast cancer study group (IBCSG) trials: Practical issues and factors associated with missing data

Statistics in Medicine

Volumn 17, Issue 5-7, 1998, Pages 587-601

  Bernhard, Jürg ^a,f   Peterson, Harriet F ^b   Coates, Alan S ^c   Gusset, Heidi ^a   Isley, Mary ^d   Hinkle, Rita ^d   Gelber, Richard D ^b   Castiglione Gertsch, Monica ^a   Hürny, Christoph ^e  

^a IBCSG Coordinating Center   (Switzerland)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

^d FRONTIER SCIENCE AND TECHNOLOGY RESEARCH FOUNDATION   (United States)

^e UNIVERSITY OF BERN   (Switzerland)

^f IBCSG Coordinating Center   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; INFORMATION PROCESSING; QUALITY OF LIFE;

EID: 2642676048     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0258(19980315/15)17:5/7<587::aid-sim806>3.0.co;2-%23     Document Type: Conference Paper

References (16)

1. Hürny, C., Bernhard, J., Coates, A. S., Castiglione-Gertsch, M., Peterson, H. F., Gelber R. D., Forbes, J. F., Rudenstam, C.-M., Simoncini, E. Crivellari, D., Goldhirsch, A. and Senn, H. J., for the International Breast Cancer Study Group. 'Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer', Lancet, 347, 1279-1284 (1996).
2. Goldhirsch, A., Gelber, R. D., Simes, R. J., Glasziou, P. and Coates, A. S., for the Ludwig Breast Cancer Study Group. 'Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis', Journal of Clinical Oncology, 7, 36-44 (1989).
3. Hürny, C., Bernhard, J., Gelber, R. D., Coates, A., Castiglione, M., Isley, M., Dreher, D., Peterson, H., Goldhirsch, A. and Senn, H. J., for the International Breast Cancer Study Group. 'Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial',. European Journal of Cancer, 28, 118-124 (1992).
4. Coates, A., Gebski, V., Bishop, J. F., Jeal, P. N., Woods, R. L., Snyder, R., Tattersall, M. H. N., Byrne, M., Harvey, V., Gill, G., Simpson, J., Drummond, R., Browne, J., Cooten, R. v. and Forbes J. F. 'Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies', New England Journal of Medicine, 317, 1490-1495 (1987).
5. Butow, P., Coates, A., Dunn, S., Bernhard, J. and Hürny, C. 'On the receiving end IV: Validation of quality of life indicators', Annals of Oncology, 2, 597-603 (1991).
6. Coates, A. S., Gebski, V., Signorini, D., Murray, P., McNeil, D., Byrne, M. and Forbes, J. F., for the Australian New Zealand Breast Cancer Trials Group. 'Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer', Journal of Clinical Oncology, 10, 1833-1838 (1992).
7. Hürny, C., Bernhard, J., Bacchi, M., Wegberg, B. v., Tomamichel, M., Spek, U., Coates, A., Castiglione, M., Goldhirsch, A. and Senn, H. J. 'The Perceived Adjustment to Chronic Illness Scale (PACIS): A global indicator of coping for operable breast cancer patients in clinical trials', Supportive Care in Cancer, 1, 200-208 (1993).
8. Zerssen D. v. 'Clinical self-rating scales (CSRS) of the Munich Psychiatric Information System (PSYCHIS Muenchen)', in Sartorius, N. and Ban, T. A. (eds), Assessment of Depression, Springer, Berlin, 1986, pp. 270-303.
9. Hürny, C., Bernhard, J., Coates, A., Peterson, H. F., Castiglione-Gertsch, M., Gelber, R. D., Rudenstam, C. M., Collins, J., Lindtner, J., Goldhirsch, A. and Senn, H. J. 'Responsiveness of a single-item indicator versus a multi-item scale: assessment of emotional well-being in an international breast cancer trial', Medical Care, 34, 234-248 (1996).
10. Hürny, C., Bernhard, J., Joss, R., Willems, Y., Cavalli, F., Kiser, J., Brunner, K., Favre, S., Alberto, P., Glaus, A., Senn, H. J., Schatzmann, E., Ganz, P. and Metzger, U., for the Swiss Group for Clinical Cancer Research SAKK. 'Feasibility of quality of life assessments in a randomized phase III trial of small cell lung cancer - a lesson from the real world', Annals of Oncology, 3, 825-831 (1992).
11. Bernhard, J., Hürny, C., Coates, A. S. and Gelber, R. D. 'Applying quality of life principles in international cancer clinical trials', in Spilker, B. (ed.), Quality of Life and Pharmacoeconomics in Clinical Trials, Lippincott-Raven Publishers, New York, 1996, pp. 693-705.
12. Hürny, C., Bernhard, J., Coates, A., Castiglione, M., Peterson, H. F., Gelber, R. D., Rudenstam, C.-M., Goldhirsch, A. and Senn, H. J., for the International Breast Cancer Study Group. 'Timing of baseline quality of life assessment in an international adjuvant breast cancer trial: Its effect on patient self-estimation', Annals of Oncology, 5, 65-74 (1994).
13. Peterson, H. F. 'Effects of timing on QL scores at month 3: Patients assigned to CMF, Trials VI and VII', Internal Report, 31 July 1996.
14. International Breast Cancer Study Group. 'Effectiveness of adjuvant chemotherapy in combination with tamoxifen for node-positive postmenopausal breast cancer patients', Journal of Clinical Oncology, 15, 1385-1394 (1997).
15. SAS Institute Inc. SAS/STAT User's Guide, Version 6, 4th edn, Volume 2, SAS Institute Inc., Cary, NC, 1989.
16. Fairclough, D. L., Peterson, H. F., Cella, D. and Bonomi, P. 'Comparison of several model-based methods for analysing incomplete quality of life data in cancer clinical trials', Statistics in Medicine, 17, 781-796 (1998).